EvON Medics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.82M
- Investors
-
5
EvON Medics General Information
Description
Developer of a neuroscience medical device designed for the treatment of Alzheimer's disease, opioid use disorder, and other neurodegenerative chronic diseases. The company's device addresses brain-related conditions and functions, including improvement of cognitive function in pre-Alzheimer's conditions such as mild cognitive impairment (MCI) and prevention of progressive neurodegeneration, enabling doctors to enrich the quality of everyone's lives through their mental well-being.
Contact Information
Website
www.evonmedics.comCorporate Office
- 6021 University Boulevard
- Suite 260
- Ellicott City, MD 21043
- United States
Corporate Office
- 6021 University Boulevard
- Suite 260
- Ellicott City, MD 21043
- United States
EvON Medics Timeline
EvON Medics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 01-Jan-2024 | $3.82M | Completed | Clinical Trials - Phase 2 | ||
| 8. Grant | 01-Aug-2023 | Completed | Clinical Trials - Phase 2 | |||
| 7. Accelerator/Incubator | 01-Mar-2023 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 20-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
| 5. Accelerator/Incubator | 02-Mar-2022 | Completed | Clinical Trials - Phase 2 | |||
| 4. Grant | 29-Apr-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Grant | 01-Jan-2020 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 30-Sep-2019 | $859K | Completed | Clinical Trials - Phase 2 | ||
| 1. Grant | 01-Jan-2018 | $450K | Completed | Startup |
EvON Medics Patents
EvON Medics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213298-A1 | Memory impairment classifier apparatus | Pending | 03-Apr-2025 | ||
| WO-2026198662-A1 | Pupillometer and related methods | Pending | 19-Mar-2025 | ||
| US-20250387588-A1 | Pain treatment apparatus and methods | Pending | 25-Jun-2024 | ||
| WO-2026006040-A1 | Pain treatment apparatus and methods | Pending | 25-Jun-2024 | ||
| CA-3201385-A1 | Olfactory testing systems and methods | Pending | 26-Aug-2020 | A61B5/4011 |
EvON Medics Signals
EvON Medics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Neurological Disorders and Stroke | Government | |||
| PitchHU | Accelerator/Incubator | |||
| National Institute on Drug Abuse (NIDA) | Government | |||
| National Institute on Aging | Government | |||
| National Institutes of Health | Government |
EvON Medics FAQs
-
When was EvON Medics founded?
EvON Medics was founded in 2013.
-
Where is EvON Medics headquartered?
EvON Medics is headquartered in Ellicott City, MD.
-
What is the size of EvON Medics?
EvON Medics has 25 total employees.
-
What industry is EvON Medics in?
EvON Medics’s primary industry is Therapeutic Devices.
-
Is EvON Medics a private or public company?
EvON Medics is a Private company.
-
What is EvON Medics’s current revenue?
The current revenue for EvON Medics is .
-
Who are EvON Medics’s investors?
National Institutes of Neurological Disorders and Stroke, PitchHU, National Institute on Drug Abuse (NIDA), National Institute on Aging, and National Institutes of Health have invested in EvON Medics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process